A Bloomberg Terminal
analyst in your browser.

Live prices, SEC filings, portfolio context, and an AI Analyst in one connected workflow.

Private beta · inviting active investors in small batches

See the whole position before you take it.

Research, with the whole picture in view.

Follow a question from the first prompt to the evidence, numbers, market context, and decision review that come after it.

Ask the question. Get the reasoning.

The AI Analyst connects your question to research context, lays out what matters next, and keeps the reasoning visible so you can challenge it.

Give me the investor-level read on Microsoft after the latest earnings.

MSFT: quality is clear, price is the question

Microsoft is still one of the strongest large-cap compounders: recurring software revenue, expanding cloud infrastructure, and a balance sheet that can fund the next leg of growth.

My read: the business is healthy, but the stock needs continued execution. The next decision point is whether Azure growth and margin expansion can justify the premium multiple.

What matters next

Growth: Azure momentum remains the cleanest proof point for the AI thesis.
Earnings quality: operating leverage is improving as cloud revenue scales.
Risk: expectations are high; a small deceleration could compress the multiple.

Bottom line: a high-quality business to keep researching, not a price-insensitive buy. I would watch the next earnings release before adding aggressively.

See the business behind the price.

Start with a single stock and move through the company overview, investment snapshot, earnings, valuation, risks, and performance.

Stocks/MSFT

MSFTTechnology

$512.08 +$9.34 · +1.86%

Updated 2 Sep, 14:32 BST · Market open

Company overview

Understand the business before the numbers.

Microsoft develops software, cloud infrastructure, productivity tools, and devices for businesses and consumers. Azure is the key growth engine, while recurring subscriptions support durable cash generation.

Quick read

Growth is the clearest positive in the quick read. Use the signals below to balance that strength against price and risk.

TechnologySoftware—InfrastructureUnited States

Investment snapshot

Four questions, answered simply

A fast read from the latest available market and company data.

Growth

Healthy

Revenue is +16.0% year over year and earnings are +19.0%.

Revenue growth +16.0%

Earnings growth +19.0%

Profitability

Strong

The company keeps 43.1% of revenue as profit. That gives the business room to absorb surprises.

Profit margin 43.1%

Operating margin 45.0%

Financial health

Healthy

Debt is greater than cash, so balance-sheet resilience matters more to the investment case.

Cash 76.8B

Debt 78.4B

Current ratio 1.8x

Debt / equity 0.5%

Valuation

Expensive

Investors are paying a premium for each dollar of expected earnings. The business needs to keep delivering to justify that price.

Expected earnings multiple 31.4x

Recent earnings multiple 38.7x

Recent briefing

What changed?

Earnings beat expectations

Reported EPS $4.62 versus $4.58 expected (+87.0%).

Revenue beat expectations

Reported revenue was 76.4B versus 75.9B expected (+0.7%).

Next earnings

29 October 2026 · EPS estimate $4.78.

Plain-English valuation

Is the stock expensive?

Expensive

The market is valuing the company at 31.4x its expected earnings. That is a useful first check, not a complete answer.

Lower multipleHigher multiple

Expected earnings

31.4x

Recent earnings

38.7x

Keep in view

Risks that could change the story

The share price assumes strong future earnings growth; a miss could reset expectations quickly.
Debt is higher than cash, making interest rates and refinancing more important to the story.

Price performance

+16.91% · 1M

Everything you need to research clearly.

One connected workspace for finding ideas, checking the evidence, and keeping your decisions grounded in context.

AI AnalystInvestigate companies, earnings, filings, financial statements, and market context in one connected workflow.Stock researchMove from a company question to evidence, analysis, portfolio context, and a decision review.SEC filing analysisSearch 10-K, 10-Q, and 8-K filings with AI assistance while keeping the source material in view.Portfolio analysisReview portfolio context, diversification, risk exposure, and the relationship between holdings and ideas.Natural-language screeningTurn an investing idea into supported screening criteria, then investigate the companies that match.Real-time market dataUse intraday pricing, volume, and market-hours context across equities, ETFs, watchlists, and research.

Questions, answered.

What is Ecomerate?

A connected research workflow for independent investors. Quotes, company filings, earnings analysis, screening, portfolios, and an AI Analyst sit in one place instead of six tabs.

How do I get access?

Ecomerate is in private beta. Join the beta list and we're inviting active investors in small batches — no credit card required.

How does the free trial work?

Every paid plan starts with 7 days free. After the trial it bills monthly at the plan price, and you can cancel anytime from your account settings.

Can I connect my brokerage account?

Yes. Ecomerate syncs positions through SnapTrade, a secure broker connection service. Your brokerage credentials stay with SnapTrade and never reach our servers.

What can I ask the AI Analyst?

Anything you would ask a research partner: earnings quality, valuation, filing changes, or the case against your own thesis. Answers arrive with the evidence attached so you can check the reasoning.

What markets does Ecomerate cover?

More than 12,400 tickers across US equities and ETFs, with live quotes during market hours and a daily recap for your watchlist.

Private beta is open.

We're inviting active investors in small batches. Join the list for early access.

Join the Beta

MSFT: quality is clear, price is the question

Microsoft is still one of the strongest large-cap compounders: recurring software revenue, expanding cloud infrastructure, and a balance sheet that can fund the next leg of growth.

My read: the business is healthy, but the stock needs continued execution. The next decision point is whether Azure growth and margin expansion can justify the premium multiple.

What matters next

Growth: Azure momentum remains the cleanest proof point for the AI thesis.

Earnings quality: operating leverage is improving as cloud revenue scales.

Risk: expectations are high; a small deceleration could compress the multiple.

Bottom line: a high-quality business to keep researching, not a price-insensitive buy. I would watch the next earnings release before adding aggressively.

Stocks/MSFT

MSFTTechnology

$512.08 +$9.34 · +1.86%

Updated 2 Sep, 14:32 BST · Market open

Company overview

Understand the business before the numbers.

Quick read

Growth is the clearest positive in the quick read. Use the signals below to balance that strength against price and risk.

TechnologySoftware—InfrastructureUnited States

Investment snapshot

Four questions, answered simply

A fast read from the latest available market and company data.

Growth

Healthy

Revenue is +16.0% year over year and earnings are +19.0%.

Revenue growth +16.0%

Earnings growth +19.0%

Profitability

Strong

The company keeps 43.1% of revenue as profit. That gives the business room to absorb surprises.

Profit margin 43.1%

Operating margin 45.0%

Financial health

Healthy

Debt is greater than cash, so balance-sheet resilience matters more to the investment case.

Cash 76.8B

Debt 78.4B

Current ratio 1.8x

Debt / equity 0.5%

Valuation

Expensive

Investors are paying a premium for each dollar of expected earnings. The business needs to keep delivering to justify that price.

Expected earnings multiple 31.4x

Recent earnings multiple 38.7x

Recent briefing

What changed?

Earnings beat expectations

Reported EPS $4.62 versus $4.58 expected (+87.0%).

Revenue beat expectations

Reported revenue was 76.4B versus 75.9B expected (+0.7%).

Next earnings

29 October 2026 · EPS estimate $4.78.

Plain-English valuation

Is the stock expensive?

Expensive

The market is valuing the company at 31.4x its expected earnings. That is a useful first check, not a complete answer.

Lower multipleHigher multiple

Expected earnings

31.4x

Recent earnings

38.7x

Keep in view

Risks that could change the story

The share price assumes strong future earnings growth; a miss could reset expectations quickly.
Debt is higher than cash, making interest rates and refinancing more important to the story.

Price performance

+16.91% · 1M

Questions, answered.

What is Ecomerate?

A connected research workflow for independent investors. Quotes, company filings, earnings analysis, screening, portfolios, and an AI Analyst sit in one place instead of six tabs.

How do I get access?

Ecomerate is in private beta. Join the beta list and we're inviting active investors in small batches — no credit card required.

How does the free trial work?

Every paid plan starts with 7 days free. After the trial it bills monthly at the plan price, and you can cancel anytime from your account settings.

Can I connect my brokerage account?

Yes. Ecomerate syncs positions through SnapTrade, a secure broker connection service. Your brokerage credentials stay with SnapTrade and never reach our servers.

What can I ask the AI Analyst?

Anything you would ask a research partner: earnings quality, valuation, filing changes, or the case against your own thesis. Answers arrive with the evidence attached so you can check the reasoning.

What markets does Ecomerate cover?

More than 12,400 tickers across US equities and ETFs, with live quotes during market hours and a daily recap for your watchlist.

A Bloomberg Terminal analyst in your browser.

Research, with the whole picture in view.

Ask the question. Get the reasoning.

MSFT: quality is clear, price is the question

What matters next

See the business behind the price.

Understand the business before the numbers.

Four questions, answered simply

Growth

Profitability

Financial health

Valuation

What changed?

Is the stock expensive?

Risks that could change the story

Price performance

Everything you need to research clearly.

Questions, answered.

Private beta is open.

A Bloomberg Terminal analyst in your browser.

Research, with the whole picture in view.

Ask the question. Get the reasoning.

MSFT: quality is clear, price is the question

What matters next

See the business behind the price.

Understand the business before the numbers.

Four questions, answered simply

Growth

Profitability

Financial health

Valuation

What changed?

Is the stock expensive?

Risks that could change the story

Price performance

Everything you need to research clearly.

Questions, answered.

Private beta is open.

A Bloomberg Terminal
analyst in your browser.

A Bloomberg Terminal
analyst in your browser.